215 related articles for article (PubMed ID: 37391740)
1. Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome.
Emami N; Alizadeh A; Maleki-Hajiagha A; Dizavi A; Vesali S; Moini A
J Ovarian Res; 2023 Jun; 16(1):127. PubMed ID: 37391740
[TBL] [Abstract][Full Text] [Related]
2. Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS.
Garg D; Grazi R; Lambert-Messerlian GM; Merhi Z
J Assist Reprod Genet; 2017 Nov; 34(11):1507-1513. PubMed ID: 28825156
[TBL] [Abstract][Full Text] [Related]
3. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome.
Wang B; Hao M; Yang Q; Li J; Guo Y
J Assist Reprod Genet; 2016 Jul; 33(7):959-65. PubMed ID: 27011370
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study.
Tong YW; Ko JKY; Lam KSL; Tam S; Lee VCY; Ho PC; Ng EHY; Li RHW
Reprod Biol Endocrinol; 2023 May; 21(1):41. PubMed ID: 37165411
[TBL] [Abstract][Full Text] [Related]
5. Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian reserve.
Merhi Z; Irani M; Doswell AD; Ambroggio J
J Clin Endocrinol Metab; 2014 Feb; 99(2):E226-33. PubMed ID: 24276462
[TBL] [Abstract][Full Text] [Related]
6. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and female infertility: the role of follicular fluid soluble receptor of advanced glycation end-products (sRAGE) in women with endometriosis.
Sopasi F; Spyropoulou I; Kourti M; Vasileiadis S; Tripsianis G; Galazios G; Koutlaki N
Hum Fertil (Camb); 2023 Dec; 26(6):1400-1407. PubMed ID: 37811816
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of sRAGE in follicular fluid from patients with PCOS.
Wang B; Li J; Yang Q; Zhang F; Hao M; Guo Y
Reproduction; 2017 Mar; 153(3):285-292. PubMed ID: 27965400
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.
Irani M; Minkoff H; Seifer DB; Merhi Z
J Clin Endocrinol Metab; 2014 May; 99(5):E886-90. PubMed ID: 24606102
[TBL] [Abstract][Full Text] [Related]
10. Follicular fluid 25-hydroxyvitamin D levels determine fertility outcome in patients with polycystic ovary syndrome.
Ozyurt R; Karakus C
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):620-625. PubMed ID: 35779910
[TBL] [Abstract][Full Text] [Related]
11. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
[TBL] [Abstract][Full Text] [Related]
12. Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome.
Tao T; Xu B; Liu W
Reprod Biol Endocrinol; 2013 Oct; 11():99. PubMed ID: 24144083
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between follicular fluid sRAGE level and ovarian responsiveness in non-PCOS patients undergoing controlled ovarian hyperstimulation].
Li M; Shao Y; Fu H; Zhou C; Yao B; Tan Y
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1482-1486. PubMed ID: 31907148
[TBL] [Abstract][Full Text] [Related]
14. Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.
Nejabati HR; Mota A; Farzadi L; Ghojazadeh M; Fattahi A; Hamdi K; Nouri M
J Endocrinol Invest; 2017 Feb; 40(2):207-215. PubMed ID: 27664102
[TBL] [Abstract][Full Text] [Related]
15. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
17. Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome.
Patil K; Hinduja I; Mukherjee S
Hum Reprod; 2021 Mar; 36(4):1052-1064. PubMed ID: 33377483
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between advanced glycation end products and vitamin D: A compelling paradigm for the treatment of ovarian dysfunction in PCOS.
Merhi Z
Mol Cell Endocrinol; 2019 Jan; 479():20-26. PubMed ID: 30170183
[TBL] [Abstract][Full Text] [Related]
19. sRAGE plays a role as a protective factor in the development of PCOS by inhibiting inflammation.
Wang BJ; Qian L; Li J; Wang F; Yang QL; Li G; Liang YL; Guo YH
Gynecol Endocrinol; 2020 Feb; 36(2):148-151. PubMed ID: 31248316
[TBL] [Abstract][Full Text] [Related]
20. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
